A innovative therapeutic frontier is hybrid chains. These engineered compounds merge segments of different peptide families, facilitating the development of distinct therapeutic characteristics. This strategy offers a https://chimerapeptides691443.bloginwi.com/77463372/chimera-peptides-a-novel-therapeutic-frontier